Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Calcitriol Oral Solution

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 11 USDMF, 7 CEP/COS, 3 JDMF, 2 EU WC, 5 KDMF, 6 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers, 35 FDA Orange Book, 55 Europe, 8 Canada, 16 Australia, 1 South Africa, 17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG, CAPSULE;ORAL - 0.5MCG, INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 8 DKSH, 3 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 7 Kirsch Pharma, 4 ACG Worldwide, 5 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 1 CD Formulation, 1 Finar, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 2 Microlex e.U, 3 Pluviaendo, 1 Qualicaps, 19 Roquette, 4 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders, 23 Parenteral, 17 Taste Masking, 16 Chewable & Orodispersible Aids, 14 Direct Compression, 12 Film Formers & Plasticizers, 10 Thickeners and Stabilizers, 10 Disintegrants & Superdisintegrants, 9 Solubilizers, 9 Topical, 8 Coating Systems & Additives, 8 Empty Capsules, 6 Co-Processed Excipients, 4 Granulation, 3 Coloring Agents, 3 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 5 News #PharmaBuzz

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 40 Regulatory FDF Prices, 8 Annual Reports

MARKET PLACE

10 APIs, 13 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	TAPI Technology & API Services	Israel	TAPI NL B.V. Amsterdam NL	CEP 1998-055 - Rev 09	Calcitriol	2025-11-06	Valid	Chemical		883
29/11/2025	CARBOGEN AMCIS AG	Switzerland	CARBOGEN AMCIS B.V. Veenendaal NL	CEP 1996-009 - Rev 13	Calcitriol	2024-12-13	Valid	Chemical and TSE		883

Calcitriol Oral Solution

Calcitriol Oral Solution

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

11 USDMF

7 CEP/COS

3 JDMF

2 EU WC

5 KDMF

6 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

132 FDF Dossiers

35 FDA Orange Book

55 Europe

8 Canada

16 Australia

1 South Africa

17 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 0.25MCG

CAPSULE;ORAL - 0.5MCG

INJECTABLE;INJECTION - 0.001MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 0.002MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Rochem International Inc

17 SPI Pharma

8 DKSH

3 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

5 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 BASF

1 CD Formulation

1 Finar

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

2 Microlex e.U

3 Pluviaendo

1 Qualicaps

19 Roquette

4 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

35 Fillers, Diluents & Binders

23 Parenteral

17 Taste Masking

16 Chewable & Orodispersible Aids

14 Direct Compression

12 Film Formers & Plasticizers

10 Thickeners and Stabilizers

10 Disintegrants & Superdisintegrants

9 Solubilizers

9 Topical

8 Coating Systems & Additives

8 Empty Capsules

6 Co-Processed Excipients

4 Granulation

3 Coloring Agents

3 Surfactant & Foaming Agents

2 Emulsifying Agents

INJECTABLE;INJECTION - 0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons